According to Latest Report on Australia Anti-Acne Drug Market 2023 to Grow with an Impressive CAGR

Report Overview

The Australia Anti-Acne Drug market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Acne is a very common skin condition. It causes spots and painful bumps on the skin. It is most noticeable on the face, but can also appear on the back, shoulders, and buttocks. Severe acne can cause scarring. Acne usually starts in puberty, but it affects adults too. Acne will usually go away on its own, but it can take many years. Some treatments can help clear acne more quickly. Over-the-counter treatments can help with mild acne. Ask a pharmacist for advice on which treatment could help and how long you will have to use it. You should not expect to see results for several weeks, even a couple of months. If over-the-counter treatments do not help after 6 to 8 weeks, treatments are available on prescription. Acne is a common condition that is associated with significant physical and psychological morbidity. It is so common it can be considered almost universal in teenagers, with a prevalence of 93.3% in people aged 1618 years in Australia. Other international studies have shown a prevalence of 85% in people aged 1224 years, and of 64% and 43% in those aged 2029 years and 3039 years, respectively. Acne can be considered a chronic disease.

Market Drivers

An increase in prevalence and severity of acne diseases is the major factor that contributes toward the growth of the acne medication market. Acne vulgaris is the most common skin problem amongst the teenaged population, with women being affected at higher rates than men. Moreover, other factors that fuel the market include an unhealthy urban lifestyle and the presence of robust acne medications in the pipeline. However, side-effects associated with the use of acne medications and the presence of alternative treatments impede the market growth. Conversely, the development of effective medications with lesser side effects and high market potential in untapped emerging economies is expected to provide lucrative growth opportunities for the market growth. Various factors such as fluctuating hormone levels, unhygienic lifestyle, and excessive production of oil from sebaceous glands have increased the prevalence of acne, thereby positively affecting the market growth.

Type of Acne Medication

Topical therapies dominated the market in 2017 by route of administration. Retinoids, antibiotics, BPO, salicylic acid, and azelaic acid are administered topically for mild-to-moderate acne as well as maintenance therapy. Oral medications are recommended as systemic therapies after topical treatments fail to evoke a response.

Treatment of severely inflamed or cystic acne may require cortisone injections. The emergence of biologics is likely to fuel the growth of injectables. Gevokizumab (Novartis/XOMA), RA-18C3 (XBiotech), and CJM112 (Novartis) are investigational monoclonal antibodies for acne treatment. All three candidates involve a subcutaneous mode of injection.

Get Exclusive Free Sample Report @ https://www.prudentmarkets.com/sample-request/140019/

Major Players

Key players operating in the acne medication market include Allergan, Bayer, Almirall, Bausch Health Companies Inc., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Galderma, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc, and Teva Pharmaceutical Industries Ltd.

The report delivers the challenges in front of the Australia Anti-Acne Drug Market 2023 that allows a better understanding of the market providing a helpful comprehensive evaluation and clear-cut dynamics associated with this market. The analyst has studied the current market scenario while concentrating on the new business objectives with the lucrative opportunities that are available. This report includes changes in customer requirements, customer preferences, and the vendor landscape in the industry with key factors that are expected to influence the overall dynamics of the Australia Anti-Acne Drugs Market including the current trends, growth opportunities, restraints, and market drivers.

To Know More About COVID-19 Impact On Australia Anti-Acne Drug Market @ https://www.prudentmarkets.com/sample-request/140019/

Market Segmentation

By Therapeutics Class:

Based on the therapeutic class, the market is segmented into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. Retinoids and antibiotics remain the mainstay of the acne drug market. Retinoids dominated the therapeutic classes in 2017, closely followed by antibiotics. It is expected that retinoids will prevail as market leaders through 2025, driven by their first-line action and impending approval of pipeline products. Antibiotics are often administered in combination with benzoyl peroxide to prevent antibiotic resistance.

The treatment paragon is likely to shift from monotherapy to combination therapy. Combination therapeutics are gaining traction on account of higher efficacy, improved results, reduced resistance, and convenient usage.

Hormonal agents are generally used in severe cases. Oral contraception is a well-known form of hormonal treatment for acne. This method is often preferred by women who, in addition to suffering from acne, have an interest in contraceptive benefits. However, hormonal therapy is not stand-alone and is synergistically combined with benzoyl peroxide, azelaic acid, antibiotics, and retinoids. Other agents used for treatment include sulfur, hydroxy acids, BPO, salicylic acid, and azelaic acid.

By Type:

Based on the type, the market is segmented into OTC and prescription drugs. The prescription medicine segment is the revenue-generating segment in the acne medication market. Prescription acne products such as antibiotics are usually combined with benzoyl peroxide or a topical retinoid that makes up for an effective combination, which is anticipated to drive the prescription acne medication market during the forecast period. On the other hand, the over-the-counter medicine segment is anticipated to register a high CAGR during the forecast period, owing to rise in preference of patient population who use over the counter (OTC) products as they are convenient to purchase and inexpensive in nature, which propels the acne medication market growth.

Major Players

Key players operating in the acne medication market include Allergan, Bayer, Almirall, Bausch Health Companies Inc., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Galderma, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc, and Teva Pharmaceutical Industries Ltd.

The Australia Anti-Acne Drug Market report is an easy-to-understand document giving section-wise details about the global market. Starting with the brief outline of the overall market, it will put forth the all-inclusive evaluated market statistics and different parameters for the forecast period. The report covers numerous aspects of the Australia Anti-Acne Drug market divided into product kind, application, and end-use, offering the report to assist the customers in improving their ability to make precise decisions related to the business under the Australia Anti-Acne Drug Market.

International Market Players will use the correct market facts and figures and applied math studies provided within the report back to perceive this and future growth of the worldwide Electrophoretic Australia Anti-Acne Drug market. Each section of the research study is specially prepared to explore key aspects of the global Australia Anti-Acne Drug Market. Buyers of the report will have access to accurate PESTLE, SWOT, and other types of analysis on the global Australia Anti-Acne Drug market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries.

This post-pandemic business planning research will aid clients to:
• Adjust their strategic planning to move ahead once business stability kicks in.
• Build resilience by making effective resource and investment choices for individual business units, products, and service lines.
• Conceptualize scenario-based planning to mitigate future crisis situations.

Instant Buy This Report and Get Up To 40% Discount [Use Corporate Email ID]: https://www.prudentmarkets.com/discount-request/140019/

Get full copy of 225+ pages research report (Inclusion of updated research on COVID-19) on United States Region at $1500 and, Europe region at $2000. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Our qualified team of researchers, analysts, and consultants use in-depth qualitative research, quantitative research, and the latest recognized research techniques to offer an unrivaled level of detail and value to your research activities. Our market and competitive intelligence can be utilized by teams across multiple departments, including sales and business development, marketing, to:

• Access the latest information on potential competitors and customers through a comprehensive database
• Analyse the business strategies and collaborations of multiple companies within a specific market
• Identify new markets and regions for future expansion
• Compare financial trends between competitor companies
• Get to know about mergers and acquisitions
• Explore the strengths and weaknesses of companies cross-industry
• Improve your business modeling

Strategic Points Covered in Table of Content of Global Australia Anti-Acne Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Australia Anti-Acne Drug market
Chapter 2: Exclusive Summary - the basic information of the Australia Anti-Acne Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Australia Anti-Acne Drug
Chapter 4: Presenting the Australia Anti-Acne Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Australia Anti-Acne Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

(If you have any special requirements, please let us know and we will offer you the report as you want.)

Inquire Before Purchasing The Complete Report To Grow Your Business: https://www.prudentmarkets.com/enquiry-request/140019/

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.